Sara Tolaney, MD, MPH, Dana-Farber Harvard Cancer Center
Advertisement
Articles by Sara Tolaney, MD, MPH, Dana-Farber Harvard Cancer Center
Advertisement
Latest Updated Articles
Perioperative Therapy: ASCO 2020 Data UpdatesPublished: August 13th 2020 | Updated:
Metastatic HR+ Breast Cancer UpdatesPublished: August 13th 2020 | Updated:
Metastatic Triple-Negative Breast Cancer Ongoing TrialsPublished: August 13th 2020 | Updated:
ASCO 2020 Data Updates: Metastatic HER2+ Breast CancerPublished: August 13th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5